Psoriasis Drug Market is Expected to Reach US$27.57 Billion with 6.9% CAGR by 2034 | Fact.MR Report
December 02, 2024 07:30 ET
|
FACT.MR
Rockville, MD, Dec. 02, 2024 (GLOBE NEWSWIRE) -- People in today's world are actively seeking ways to make their immune systems robust, especially after the COVID pandemic shook the world. Psoriasis...
Derm-Biome Pharmaceuticals adds Dr. Jerry Tan, internationally renowned expert in acne and acne scarring, to its Scientific Advisory Board
November 25, 2024 10:00 ET
|
Derm-Biome Pharmaceuticals, Inc
VANCOUVER, British Columbia, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Derm-Biome Pharmaceuticals, Inc, a Vancouver-based biopharmaceutical company developing safe and highly effective topical treatments...
2024 Beauty Innovation Awards Recognize Dear Brightly With “Personalized Skin Care Product of the Year” for Their Innovative TeleHealth Beauty Platform
November 20, 2024 11:25 ET
|
Beauty Innovation Awards
LOS ANGELES, Nov. 20, 2024 (GLOBE NEWSWIRE) -- The 2024 Beauty Innovation Awards today announced that Dear Brightly, an innovative skincare brand that bridges the gap between telehealth and beauty,...
OMEICOS Therapeutics Completes Enrollment of PMD-OPTION Study in Primary Mitochondrial Disease
September 26, 2024 06:00 ET
|
OMEICOS Therapeutics GmbH
Interim data confirms OMT-28’s strong safety profile in PMD patients, top-line data expected mid-2025 BERLIN, GERMANY, September 26, 2024 – OMEICOS, a biopharmaceutical company developing...
ImmuneSensor Therapeutics Receives Clearance from Australian Regulators to Initiate a First-in-Human Phase 1 Clinical Trial of cGAS inhibitor Drug Candidate, IMSB301
August 19, 2024 08:00 ET
|
ImmuneSensor Therapeutics
Novel, oral IMSB301 is a potent cGAS inhibitor designed to block signaling through a central pathway that drives diverse inflammatory and autoimmune diseases Company expects to initiate its Phase 1...
Ashwagandha Market is Likely to Reach USD 1.9 billion by 2034 at a CAGR of 9.2% | Report Analysis by Transparency Market Research Inc.
August 12, 2024 05:24 ET
|
Transparency Market Research
Wilmington, Delaware, United States, Transparency Market Research Inc. -, Aug. 12, 2024 (GLOBE NEWSWIRE) -- The global ashwagandha market (아슈와간다 시장) was projected to attain US$ 692.9 million in...
Snif-Snax Wins “Natural Dog Treat Product of the Year” In 2024 Pet Innovation Awards
August 06, 2024 08:00 ET
|
Pet Innovation Awards
LOS ANGELES, Aug. 06, 2024 (GLOBE NEWSWIRE) -- The 2024 Pet Innovation Awards, an independent recognition platform highlighting the most innovative companies, services, and products in the highly...
Derm-Biome Pharmaceuticals and TransBIOtech awarded $450,000 Applied Research and Development (ARD) grant funding
May 08, 2024 10:00 ET
|
Derm-Biome Pharmaceuticals, Inc
VANCOUVER, British Columbia, May 08, 2024 (GLOBE NEWSWIRE) -- Derm-Biome Pharmaceuticals, Inc, a Vancouver based biopharmaceutical company focused on skin health and healthy aging, is pleased to...
Derm-Biome Pharmaceuticals prepares to begin IND-enabling studies for DB-007-4, a potential best-in-class treatment for inflammatory skin diseases
February 27, 2024 10:00 ET
|
Derm-Biome Pharmaceuticals, Inc
VANCOUVER, British Columbia, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Derm-Biome Pharmaceuticals Inc, a Vancouver-based biopharmaceutical company developing novel topical therapies for inflammatory skin...
Basil Extracts Market to exceed $1.5 Bn by 2032, Says Global Market Insights Inc.
January 17, 2024 20:30 ET
|
Global Market Insights Inc.
Selbyville, Delaware, Jan. 17, 2024 (GLOBE NEWSWIRE) -- The basil extracts market valuation is anticipated to reach USD 1.5 billion by 2032, as reported in a research study by Global Market...